Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-27T06:45:57.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site revision label on the 403 Forbidden page changed from v3.7.1 to v3.7.2; the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-20T08:21:35.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T08:17:57.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the full study record, indicating that access to the study details is blocked. As a result, the detailed content previously visible on the page is no longer accessible.
    Difference
    19%
    Check dated 2026-09-22T06:29:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added related topics for Melanoma and MedlinePlus Genetics to the page. This expands navigational and contextual context around the study without altering core content.
    Difference
    0.2%
    Check dated 2026-09-15T02:11:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s related topics area was streamlined by removing the Melanoma entry, the related topics header, and the MedlinePlus Genetics link, reducing the list of linked topics shown for the study.
    Difference
    0.2%
    Check dated 2026-09-08T00:50:00.000Z thumbnail image

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.